About this release
This release by Public Health Scotland presents the Scottish Renal Registry (SRR) 2020 Annual National Report. The SRR aims to improve the care of patients with established renal failure treated with renal replacement therapy (RRT).
This fifteenth SRR report presents information about the causes, incidence, prevalence, distribution, methods of treatment and outcome of patients receiving RRT for established renal failure (ERF) in Scotland between 1960 and 31 December 2019.
- In 2019, 571 people (105 per million population) started RRT for ERF.
- On 31 December 2019 there were 5,436 prevalent patients receiving RRT, 61% of whom had a functioning kidney transplant, 35% were being treated with haemodialysis (HD) and 4% with peritoneal dialysis (PD).
- 297 patient’s resident in Scotland received a kidney transplant in Scotland in 2019. 20% of these transplants were pre-emptive (performed before the patient had required any other form of RRT) compared with 17% in 2018.
- 31% of kidney transplants performed in 2019 were from living donors compared with 35% in 2018.
- There is a significant trend of improving survival of function of transplanted kidneys from 1960 – 2019 and also patient survival following kidney transplantation up to 10 years’ post-transplant.
- There has been a gradual reduction in the number of Staphylococcus aureus bacteraemia (SAB)s recorded in those being treated with HD between 2016-2019.
Incidence of MRSA & MSSA bacteraemia in HD RRT patients in Scotland 2015 to 2019
MRSA= methicillin-resistant Staphylococcus aureus
MSSA= methicillin-sensitive Staphylococcus aureus
SRR is within the Scottish National Audit Programme which is now part of the newly formed Public Health Scotland. SRR’s aim is to improve the care of patients with ERF treated with RRT by systematic and comprehensive analysis, including audits, of service provision, clinical management and outcomes.
Please visit the SRR website (external website) for more information.
The next release of this publication will be in summer 2021.
If you have an enquiry relating to this publication, please email firstname.lastname@example.org.
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email email@example.com.
To report any issues with a publication, please email firstname.lastname@example.org.